Effect of SCF and of various cytokines on the proliferation of the 2 different ROSA cell lines. (A) ROSAKIT WT or ROSAKIT D816V cells were treated or not treated with rhSCF (80 ng/mL) for 4 days at 37°C. At each time point, 10 μL of 3-(4,5-dimethyltiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was added in corresponding wells, and the cells were incubated for 3 additional hours in an incubator at 37°C. The number of living cells was then measured for each condition by reading the absorbance at 570 nm. (B) ROSAKIT WT (with or without SCF) or ROSAKIT D816V cells (without SCF) were treated with various cytokines (all at 100 ng/mL) for 3 days. At that time, 10 μL of MTT was added in corresponding wells, and the cells were incubated for 3 additional hours in an incubator at 37°C. The number of living cells was then measured for each condition by reading the absorbance at 570 nm. Data presented are the mean ± standard deviation (SD) from 3 independent experiments. OD, optical density.